Genenta Science S.p.A. Ownership 2024 | Who Owns Genenta Science S.p.A. Now?


OverviewFinancialsChart

Institutional Ownership

2.37%

Insider Ownership

38.68%

Retail Ownership

58.95%

Institutional Holders

4.00

Genenta Science S.p.A. Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CARTESIAN GROWTH CORP1.10%0.02%200,288200,288100.00%620,893Jun 30, 2024
ALGEBRIS (UK) LTD0.25%0.04%45,000--130,623Jun 30, 2024
UBS GROUP AG0.00%-8938522078.05%2,768Jun 30, 2024
MORGAN STANLEY0.00%-500--1,550Jun 30, 2024
BANK JULIUS BAER & CO. LTD, ZURICH----385,313-100.00%-Jun 30, 2024

Genenta Science S.p.A.'s largest institutional shareholder is CARTESIAN GROWTH CORP, holding 1.10% of the company's total share outstanding, currently valued at $620.89K. The top 10 institutional shareholders own together 1.35% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ALGEBRIS (UK) LTD0.25%0.04%45,000--130,623Jun 30, 2024
CARTESIAN GROWTH CORP1.10%0.02%200,288200,288100.00%620,893Jun 30, 2024
UBS GROUP AG0.00%-8938522078.05%2,768Jun 30, 2024
MORGAN STANLEY0.00%-500--1,550Jun 30, 2024
BANK JULIUS BAER & CO. LTD, ZURICH----385,313-100.00%-Jun 30, 2024

The largest Genenta Science S.p.A. shareholder by % of total assets is ALGEBRIS (UK) LTD. The company owns 45.00K shares of Genenta Science S.p.A. (GNTA), representing 0.04% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CARTESIAN GROWTH CORP1.10%0.02%200,288200,288100.00%620,893Jun 30, 2024
UBS GROUP AG0.00%-8938522078.05%2,768Jun 30, 2024
MORGAN STANLEY0.00%-500--1,550Jun 30, 2024
ALGEBRIS (UK) LTD0.25%0.04%45,000--130,623Jun 30, 2024
BANK JULIUS BAER & CO. LTD, ZURICH----385,313-100.00%-Jun 30, 2024

As of Jun 30 2024, Genenta Science S.p.A.'s largest institutional buyer is CARTESIAN GROWTH CORP. The company purchased 200.29K stocks of GNTA, valued at $620.89K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BANK JULIUS BAER & CO. LTD, ZURICH----385,313-100.00%-Jun 30, 2024
ALGEBRIS (UK) LTD0.25%0.04%45,000--130,623Jun 30, 2024
MORGAN STANLEY0.00%-500--1,550Jun 30, 2024
UBS GROUP AG0.00%-8938522078.05%2,768Jun 30, 2024
CARTESIAN GROWTH CORP1.10%0.02%200,288200,288100.00%620,893Jun 30, 2024

As of Jun 30 2024, Genenta Science S.p.A.'s biggest institutional seller is BANK JULIUS BAER & CO. LTD, ZURICH. The company sold -0.39M shares of GNTA, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CARTESIAN GROWTH CORP1.10%0.02%200,288200,288100.00%620,893Jun 30, 2024

Genenta Science S.p.A.'s largest new institutional shareholder by number of shares is CARTESIAN GROWTH CORP, purchased 200.29K shares, valued at $620.89K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BANK JULIUS BAER & CO. LTD, ZURICH----385,313-100.00%-Jun 30, 2024

Genenta Science S.p.A.'s largest sold out institutional shareholder by shares sold is BANK JULIUS BAER & CO. LTD, ZURICH, sold -0.39M shares, valued at -, as of undefined.

Genenta Science S.p.A. Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 244-
31 Dec, 23433.33%
30 Sep, 233-25.00%
30 Jun, 234100.00%
31 Mar, 232-50.00%
31 Dec, 224100.00%
30 Sep, 222-33.33%
30 Jun, 223-
31 Mar, 22350.00%
31 Dec, 212-

As of 31 Mar 24, 4 institutions are holding Genenta Science S.p.A.'s shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 24430,854-6.41%
31 Dec, 23460,3480.50%
30 Sep, 23458,047-0.15%
30 Jun, 23458,747908.24%
31 Mar, 2345,500-7.25%
31 Dec, 2249,0581290.53%
30 Sep, 223,528-4.88%
30 Jun, 223,709-92.17%
31 Mar, 2247,3740.45%
31 Dec, 2147,163-

Genenta Science S.p.A. (GNTA) has 430.85K shares outstanding as of 31 Mar 24, down -6.41% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 242.37%37.04%
31 Dec, 232.53%39.97%
30 Sep, 232.51%39.65%
30 Jun, 232.52%4036.19%
31 Mar, 230.25%344.41%
31 Dec, 220.27%71676.80%
30 Sep, 220.02%3201.63%
30 Jun, 220.02%24.93%
31 Mar, 220.31%321.23%
31 Dec, 210.31%-

As of 31 Mar 24, Genenta Science S.p.A. is held by 2.37% institutional shareholders, representing a 37.04% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 24--100.00%
31 Dec, 231-
30 Sep, 23--100.00%
30 Jun, 232-
31 Mar, 23--100.00%
31 Dec, 223200.00%
30 Sep, 221-50.00%
30 Jun, 222100.00%
31 Mar, 221-50.00%
31 Dec, 212-

- institutional shareholders have increased their position in GNTA stock as of 31 Mar 24 compared to 1 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 242-
31 Dec, 23--
30 Sep, 23--
30 Jun, 23--
31 Mar, 23--
31 Dec, 22--
30 Sep, 22--100.00%
30 Jun, 221-
31 Mar, 221-
31 Dec, 21--

2 institutional shareholders have reduced their position in GNTA stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 244-430,854-6.41%2.37%37.04%--100.00%2-
31 Dec, 23433.33%460,3480.50%2.53%39.97%1---
30 Sep, 233-25.00%458,047-0.15%2.51%39.65%--100.00%--
30 Jun, 234100.00%458,747908.24%2.52%4036.19%2---
31 Mar, 232-50.00%45,500-7.25%0.25%344.41%--100.00%--
31 Dec, 224100.00%49,0581290.53%0.27%71676.80%3200.00%--
30 Sep, 222-33.33%3,528-4.88%0.02%3201.63%1-50.00%--100.00%
30 Jun, 223-3,709-92.17%0.02%24.93%2100.00%1-
31 Mar, 22350.00%47,3740.45%0.31%321.23%1-50.00%1-
31 Dec, 212-47,163-0.31%-2---

Genenta Science S.p.A. Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Nov 15, 2006Sanders Walter Lloydofficer VP, Sales & MarketingP-PurchaseBuy25,000$0.75$18.75K30,633
Jun 26, 2006Sanders Walter Lloydofficer VP, Sales & MarketingP-PurchaseBuy56$1.63$91.285,633
Jun 20, 2006Sanders Walter Lloydofficer VP, Sales & MarketingP-PurchaseBuy255$1.52$387.605,577
Jun 20, 2006Sanders Walter Lloydofficer VP, Sales & MarketingP-PurchaseBuy322$1.51$486.225,322
May 15, 2006Driscoll Martin Jdirector-P-PurchaseBuy15,000$1.46$21.90K15,000
May 05, 2004ROSENWALD LINDSAY A MD10 percent owner-S-SaleSell1,501,900$5.05$7.58M2,373,693

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Nov 15, 2006Sanders Walter Lloydofficer VP, Sales & MarketingP-PurchaseBuy25,000$0.75$18.75K30,633
Jun 26, 2006Sanders Walter Lloydofficer VP, Sales & MarketingP-PurchaseBuy56$1.63$91.285,633
Jun 20, 2006Sanders Walter Lloydofficer VP, Sales & MarketingP-PurchaseBuy255$1.52$387.605,577
Jun 20, 2006Sanders Walter Lloydofficer VP, Sales & MarketingP-PurchaseBuy322$1.51$486.225,322
May 15, 2006Driscoll Martin Jdirector-P-PurchaseBuy15,000$1.46$21.90K15,000

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 15, 2008Sanders Walter Lloydofficer Senior VP & COOJ-OtherSell53--5,051
Apr 15, 2008Sanders Walter Lloydofficer Senior VP & COOJ-OtherSell51--5,000
Sep 28, 2006GROOPMAN JEROMEother Former DirectorJ-OtherSell104,000---
Jan 18, 2006Sanders Walter Lloydofficer VP, Sales & MarketingSell---5,000
Jan 18, 2006Sanders Walter Lloydofficer VP, Sales & MarketingSell100,000$1.81$181.00K-
Sep 22, 2005Driscoll Martin Jdirector-Sell24,000$1.21$29.04K-
May 05, 2004ROSENWALD LINDSAY A MD10 percent owner-S-SaleSell1,501,900$5.05$7.58M2,373,693

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Oct 16, 2008Driscoll Martin Jdirector-A-AwardBuy4,999$0.25$1.25K4,999
Apr 15, 2008Sanders Walter Lloydofficer Senior VP & COOA-AwardBuy65,000$0.41$26.65K65,000
Apr 15, 2008Sanders Walter Lloydofficer Senior VP & COOJ-OtherSell53--5,051
Apr 15, 2008Sanders Walter Lloydofficer Senior VP & COOJ-OtherSell51--5,000
Jul 12, 2007Driscoll Martin Jdirector-A-AwardBuy30,000$0.30$9.00K30,000
Jan 17, 2007Sanders Walter Lloydofficer Sr VP, Commercial OperationsA-AwardBuy30,000$0.46$13.69K30,000
Nov 15, 2006Sanders Walter Lloydofficer VP, Sales & MarketingP-PurchaseBuy25,000$0.75$18.75K30,633
Sep 28, 2006GROOPMAN JEROMEother Former DirectorJ-OtherSell104,000---
Jun 27, 2006GROOPMAN JEROMEdirector-A-AwardBuy20,000$2.13$42.60K20,000
Jun 26, 2006Driscoll Martin Jdirector-A-AwardBuy20,000$2.13$42.60K20,000
Jun 26, 2006Sanders Walter Lloydofficer VP, Sales & MarketingP-PurchaseBuy56$1.63$91.285,633
Jun 26, 2006Driscoll Martin Jdirector-A-AwardBuy5,000$1.61$8.05K5,000
Jun 20, 2006Sanders Walter Lloydofficer VP, Sales & MarketingP-PurchaseBuy255$1.52$387.605,577
Jun 20, 2006Sanders Walter Lloydofficer VP, Sales & MarketingP-PurchaseBuy322$1.51$486.225,322
May 15, 2006Driscoll Martin Jdirector-P-PurchaseBuy15,000$1.46$21.90K15,000
Jan 18, 2006Sanders Walter Lloydofficer VP, Sales & MarketingSell---5,000
Jan 18, 2006Sanders Walter Lloydofficer VP, Sales & MarketingSell100,000$1.81$181.00K-
Sep 22, 2005Driscoll Martin Jdirector-Sell24,000$1.21$29.04K-
Jun 27, 2005GROOPMAN JEROMEdirector-A-AwardBuy20,000$1.11$22.20K20,000
May 05, 2004ROSENWALD LINDSAY A MD10 percent owner-S-SaleSell1,501,900$5.05$7.58M2,373,693

The last insider sell of Genenta Science S.p.A.'s stock was made by Sanders Walter Lloyd on Apr 15 2008, selling 53 shares at - per share (valued at -). The last insider buy of GNTA was made by Sanders Walter Lloyd on Nov 15 2006, buying 25,000 shares at $0.75 per share (worth $18.75K).

Genenta Science S.p.A. Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio

Genenta Science S.p.A. Peer Ownership


TickerCompany
CYTCyteir Therapeutics, Inc.
PMVPPMV Pharmaceuticals, Inc.
MLYSMineralys Therapeutics, Inc.
AVTEAerovate Therapeutics, Inc.
CSBRChampions Oncology, Inc.
JANXJanux Therapeutics, Inc.
ANTXAN2 Therapeutics, Inc.
MNOVMediciNova, Inc.
PHVSPharvaris N.V.
RZLTRezolute, Inc.
PEPGPepGen Inc.
ANEBAnebulo Pharmaceuticals, Inc.
ADAGAdagene Inc.
MOLNMolecular Partners AG
PRDSPardes Biosciences, Inc.
OPTOpthea Limited
ELYMEliem Therapeutics, Inc.

GNTA Ownership FAQ


Genenta Science S.p.A. is owned by institutional shareholders (2.37%), insiders (38.68%), and public (58.95%). The largest institutional shareholder of Genenta Science S.p.A. is CARTESIAN GROWTH CORP (1.10% of total shares) and the top mutual fund owner is (0% of total shares).

Genenta Science S.p.A.'s major institutional shareholders are CARTESIAN GROWTH CORP, ALGEBRIS (UK) LTD, UBS GROUP AG, MORGAN STANLEY, and BANK JULIUS BAER & CO. LTD, ZURICH. The top five shareholders own together 1.35% of the company's share outstanding.

As of Mar 2024, there are 4 institutional shareholders of Genenta Science S.p.A..

CARTESIAN GROWTH CORP owns 200.29K shares of Genenta Science S.p.A., representing 1.10% of the company's total shares outstanding, valued at $620.89K (as of Jun 2024).

As of Jun 2024, ALGEBRIS (UK) LTD holds 45K shares of Genenta Science S.p.A. (GNTA), compromising 0.25% of the company, valued at $130.62K.

UBS GROUP AG is the third largest holder of Genenta Science S.p.A.. The company owns 893 of the company's shares outstanding (worth $2.77K).